It doesn't sell because it doesn't have large controlled clinical trials to support their claims, only tiny studies that cannot be used to get medical reimbursement nor interest from hospitals.
FDA-Cleared just means they have permission to market it, it doesn't mean that it does anything.
Definitely not the time to put money in this stock. It is dangerously close to needing a reverse split to maintain QB status. I believe today's PR was an attempt to get volume to assist with the dilution of shares. There have been multiple days of after hour T trades.
You are correct. The Sofpulse is a viable product. It is unfortunately in the hands of the wrong person/company.
News 
Market Data 
Discover 
AI
